Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Rheumatology

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/rheumatology/ker269PMID 21900368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• [Survival and death causes in 251 systemic sclerosis patients from a single Italian center].

  2011cited by this paper
• Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies.

  2010cited by this paper
• Determinants of morbidity and mortality of systemic sclerosis in Canada.

  2010cited by this paper
• Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.

  2010cited by this paper
• Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.

  2010cited by this paper
• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  2010cited by this paper
• EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

  2009cited by this paper
• Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

  2009cited by this paper
• Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

  2009cited by this paper
• Mortality trends in systemic sclerosis in France and USA, 1980–1998: an age-period-cohort analysis

  2009cited by this paper
• Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients.

  2008cited by this paper
• Systemic sclerosis: an update.

  2008cited by this paper
• Systemic Sclerosis in Northwestern Spain: A 19-year Epidemiologic Study

  2008cited by this paper
• Systemic sclerosis: an update in 2008.

  2008cited by this paper
• Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study

  2008cited by this paper
• Systemic Sclerosis Mortality in the United States: 1999–2002 Implications for Patient Care

  2007cited by this paper
• Changes in causes of death in systemic sclerosis, 1972–2002

  2007cited by this paper
• The widening mortality gap between rheumatoid arthritis patients and the general population.

  2007cited by this paper
• Death Certificates Are Not Reliable: Revivification of the Autopsy

  2006cited by this paper
• A cohort study of cancer incidence in systemic sclerosis.

  2006cited by this paper
• Systemic Sclerosis Mortality in the United States: 1979–1998

  2005cited by this paper
• Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

  2005cited by this paper
• Controlling the risk of spurious findings from meta‐regression

  2004cited by this paper
• Risk of cancer in patients with scleroderma: a population based cohort study

  2003cited by this paper
• Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

  2003cited by this paper
• Mortality and prognostic factors in Spanish patients with systemic sclerosis.

  2003cited by this paper
• Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival

  2002cited by this paper
• Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

  2002cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale

  2001cited by this paper
• Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.

  2001cited by this paper
• Criteria for the classification of early systemic sclerosis.

  2001cited by this paper
• Severe organ involvement in systemic sclerosis with diffuse scleroderma.

  2000cited by this paper
• Long-Term Outcomes of Scleroderma Renal Crisis

  2000cited by this paper
• Long-term outcomes of scleroderma renal crisis.

  2000cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Systemic sclerosis prevalence and mortality in Sydney 1974-88.

  1999cited by this paper
• Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit.

  1999cited by this paper
• Mortality and causes of death in a Swedish series of systemic sclerosis patients

  1998cited by this paper
• Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)

  1998cited by this paper
• Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

  1997cited by this paper
• Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population.

  1996cited by this paper
• Mortality in systemic sclerosis: a comparison with the general population.

  1995cited by this paper
• Mortality in systemic sclerosis (scleroderma).

  1992cited by this paper
• Predictors of survival in systemic sclerosis (scleroderma).

  1991cited by this paper
• The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study.

  1991cited by this paper
• Scleroderma and survival.

  1991cited by this paper
• Statistical Methods in Cancer Research, Vol. 2, the Design and Analysis of Cohort Studies

  1990cited by this paper
• A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

  1988cited by this paper
• Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

  1987cited by this paper
• The design and analysis of cohort studies

  1987cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Studies on the reliability of vital and health records: I. Comparison of cause of death and hospital record diagnoses.

  1979cited by this paper
• Epidemiology of systemic sclerosis (scleroderma).

  1971cited by this paper

• Efficacy and Safety of Tofacitinib Compared to Cyclophosphamide in Early Diffuse Cutaneous Systemic Sclerosis: A Randomized Controlled Trial

  2026cites this paper
• Exploring the optimal follow-up for systemic sclerosis patients: study protocol for a Dutch multicenter randomized controlled trial.

  2026cites this paper
• Systematic Review and Model-Based Meta-Analysis of Targeted Drugs for Systemic Sclerosis.

  2026cites this paper
• Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink.

  2025cites this paper
• Early diagnostics of cardiac autonomic dysfunction in patients with systemic sclerosis

  2025cites this paper
• The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvement

  2025cites this paper
• Association of Left Atrial Dysfunction with Pulmonary Hemodynamics and Cardiovascular Outcomes in Patients with Systemic Sclerosis

  2025cites this paper
• Long-term cardiovascular outcomes after percutaneous coronary intervention in patients with systemic sclerosis

  2025influential citation
• Combination of localized scleroderma with other autoimmune skin diseases: clinical and pathogenetic aspects

  2025cites this paper
• A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis

  2025cites this paper
• Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

  2025cites this paper
• Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experience

  2025cites this paper
• Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma

  2025cites this paper
• Guidance for stem cell therapy for juvenile systemic sclerosis patients

  2025cites this paper
• Epicardial adipose tissue provides incremental value in predicting major adverse cardiac events in systemic sclerosis patients without pulmonary arterial hypertension beyond traditional risk factors

  2025cites this paper
• National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource, But with Limitations.

  2025cites this paper
• Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns

  2025cites this paper
• Autoimmune diseases' mortality: secular trends and causes.

  2025cites this paper
• Systemic sclerosis: bridging clinical and molecular insights: results from the PRECISESADS study

  2025cites this paper
• Association of Inflammation-Based Ratios with Endothelial Dysfunction Markers and Clinical Parameters in Limited Cutaneous Systemic Sclerosis

  2025cites this paper
• VE/VCO2 at ventilatory threshold and peak VO2 in CPET studies of patients with scleroderma-associated PAH: A systematic review and meta-analyses.

  2025cites this paper
• Panel of IFN-I-induced genes in systemic scleroderma: a stratification biomarker potential

  2025cites this paper
• Lungenfibrose bei systemischer Sklerose: to treat or not to treat

  2025cites this paper
• Fibrosis mechanisms and updates in potential therapeutic targets in systemic sclerosis.

  2025cites this paper
• Recombinant Human Annexin A5 Ameliorates Localized Scleroderma by Inhibiting the Activation of Fibroblasts and Macrophages

  2025cites this paper
• Predictors of systemic sclerosis patients with interstitial lung disease progression: A retrospective study

  2025cites this paper
• Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy

  2025cites this paper
• Epidemiology and effect of psychiatric comorbidities on survival rates in patients with systemic sclerosis: A nationwide population-based cohort study.

  2025cites this paper
• Noninvasive left ventricular myocardial work identifies subclinical myocardial dysfunction in patients with systemic sclerosis

  2025cites this paper
• Effects of Physalis angulata extracts on bleomycin-induced rat: analysis on lung inflammation and fibrosis

  2025cites this paper
• Arrhythmia as a Possible Complication of Mycophenolate Mofetil in Systemic Sclerosis: A Case Report

  2025cites this paper
• Identification and validation of key genes commonly expressed and upregulated in systemic sclerosis-associated lung diseases through integrated analysis.

  2025cites this paper
• Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group.

  2024cites this paper
• Lungenfibrose bei systemischer Sklerose: to treat or not to treat

  2024cites this paper
• Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis.

  2024cites this paper
• Thyroid Disorders in Systemic Sclerosis: A Comprehensive Review

  2024cites this paper
• Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis

  2024cites this paper
• [The arguments favoring autologous haematopoietic stem cell transplantation in systemic scleroderma].

  2024cites this paper
• What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey

  2024cites this paper
• Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial

  2024cites this paper
• Psychological impact of autologous hematopoietic stem cell transplantation in systemic sclerosis patients and influence of resilience

  2024cites this paper
• Prevalence, incidence, and mortality of Raynaud’s phenomenon, Sjögren’s syndrome and scleroderma: an umbrella review of systematic reviews

  2024influential citation
• Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome

  2024cites this paper
• Biological correlates of radiological features of systemic sclerosis interstitial lung disease

  2024cites this paper
• Comorbidity burden on mortality in patients with systemic sclerosis

  2024cites this paper
• The Role of Cardiac Magnetic Resonance Imaging Parameters in Prognostication of Systemic Sclerosis in Patients with Cardiac Involvement: A Systematic Review of the Literature.

  2024cites this paper
• Unraveling the role of MiR‐181 in skin fibrosis pathogenesis by targeting NUDT21

  2024cites this paper
• The 2024 British Society for Rheumatology guideline for management of systemic sclerosis

  2024cites this paper
• Circulating cell adhesion molecules in systemic sclerosis: a systematic review and meta-analysis

  2024cites this paper
• Systemic sclerosis and cancer in the UK: An epidemiological analysis using the Clinical Practice Research Datalink.

  2024cites this paper
• Tuberculosis is the predominant infection in systemic sclerosis: thirty-year retrospective study of serious infections from a single centre

  2024influential citation
• Managing Symptoms of Systemic Sclerosis for the Allergist-Immunologist

  2024cites this paper
• The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary

  2024cites this paper
• The evaluation of gastrointestinal involvement and nutritional status in systemic sclerosis: identifying risk factors for malnutrition in a cross-sectional study

  2024cites this paper
• Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study

  2024cites this paper
• Resilience partially mediates the association between perceived social isolation and life satisfaction in people with systemic sclerosis

  2024cites this paper
• Causes and predictors of death among Finnish patients with systemic sclerosis

  2024influential citation
• Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort

  2024cites this paper
• Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire

  2024cites this paper
• Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis

  2024cites this paper
• Prevalence of metabolic syndrome patıents with systemic sclerosis

  2024cites this paper
• Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

  2023cites this paper
• Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis

  2023cites this paper
• Clinically Recognized Depression and Mental Health Treatment in a Single Center Cohort of Patients with Systemic Sclerosis

  2023cites this paper
• Standardized mortality ratios in systemic sclerosis: a meta-analysis assessing overall and sex- and disease subtype-specific differences

  2023cites this paper
• Hipertensión arterial pulmonar en pacientes con dermatomiositis juvenil y esclerosis sistémica en un centro pediátrico de tercer nivel

  2023cites this paper
• Die Lunge: Ausgangspunkt vieler Erkrankungen

  2023cites this paper
• Interferon regulatory factor 7 in inflammation, cancer and infection

  2023cites this paper
• Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis

  2023influential citation
• Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis

  2023influential citation
• Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis.

  2023cites this paper
• Description of a single centre cohort of patients with systemic sclerosis from the University Hospital of Buenos Aires and factors associated with lung function deterioration. A retrospective study.

  2023cites this paper
• Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

  2023cites this paper
• Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis

  2023cites this paper
• Rituximab in the treatment of systemic sclerosis. Literature review

  2023cites this paper
• Transcutaneous auricular branch vagal nerve stimulation as a non-invasive add-on therapeutic approach for pain in systemic sclerosis

  2023cites this paper
• Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases

  2023cites this paper
• Metabolic fingerprinting of systemic sclerosis: a systematic review

  2023cites this paper
• Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study

  2022cites this paper
• Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis

  2022cites this paper
• Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells

  2022cites this paper
• Stem cell transplantation for systemic sclerosis.

  2022cites this paper
• Systemic Sclerosis

  2022cites this paper
• Consensus-based recommendations on communication and education regarding primary care physical therapy for patients with systemic sclerosis.

  2022cites this paper
• Cognitive Difficulties in People with Systemic Sclerosis: A Qualitative Study.

  2022cites this paper
• Short treatment of peripheral blood cells product with Fas ligand using closed automated cell processing system significantly reduces immune cell reactivity of the graft in vitro and in vivo

  2022cites this paper
• Survival in Patients with Systemic Sclerosis: A Single Center Cohort

  2022cites this paper
• The Prognostic Value of Right Atrial and Right Ventricular Functional Parameters in Systemic Sclerosis

  2022cites this paper
• Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis.

  2022cites this paper
• Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management

  2022cites this paper
• [Cardiopulmonary exercise testing in the management of systemic sclerosis].

  2022cites this paper
• Systemic sclerosis in Asians: Are there racial differences?

  2022cites this paper
• Scleroderma hypertensive renal crisis among systemic sclerosis patients: A national emergency department database study.

  2022cites this paper
• Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.

  2022cites this paper
• Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis

  2022cites this paper
• Very Early Diagnosis of Systemic Sclerosis in Clinical Practice - Case Report and Review of the Literature.

  2022cites this paper
• Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab

  2022cites this paper
• The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study

  2022cites this paper
• Sympatho-Vagal Dysfunction in Systemic Sclerosis: A Follow-Up Study

  2022cites this paper
• Benefits and risks of Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.

  2022cites this paper